Objective
Assuming an annual birth rate of 10.25 births/1,000 population approximately 25,000 Extremely Low Gestational Age Newborns are born every year in the EU. Conservative figures estimate that approximately half of all these babies will develop low blood pressure and require treatment. However, no uniform criteria exist to define hypotension and the evidence to support our current management strategies is limited. Many of these interventions have been derived from adult literature and have not been validated in the newborn. Dopamine remains the most common inotrope used despite little evidence that it improves outcome. Hypotension is not only associated with mortality of preterm infants but is also associated with brain injury and impaired neurosensory development in ELGAN survivors. Preterm brain injury has far reaching implications for the child, parents, family, health service and society at large. It is therefore essential that we now design and perform the appropriate trials to determine whether the infusion of inotropic agents is associated with improved outcome. We have assembled a consortium with expertise in key areas of neonatal cardiology, neonatology, neurophysiology, basic science and pharmacology with the intention of answering these questions. The objectives of the group are as follows:
1. To perform a multinational, randomized controlled trial to evaluate whether a more restricted approach to the diagnosis and management of hypotension compared to a standard approach, with dopamine as a first line inotrope, affects survival without significant brain injury at 36 weeks gestational age in infants born less than 28 weeks gestation and affects survival without neurodevelopmental disability at 2 years corrected age
2. To perform pharmacokinetic and pharmcodynamic studies of dopamine
3. To develop and adapt a formulation of dopamine suitable for newborns in order to apply for a Paediatric Use Marketing Authorization
Fields of science
Call for proposal
FP7-HEALTH-2010-single-stage
See other projects for this call
Funding Scheme
CP-FP - Small or medium-scale focused research projectCoordinator
T12 YN60 Cork
Ireland
See on map
Participants (16)
3000 Leuven
See on map
116 36 Praha 1
See on map
H3T 1C5 MONTREAL QUEBEC
See on map
4 Dublin
See on map
Dublin 8 Dublin
See on map
69007 LYON
See on map
WC1E 6BT LONDON
See on map
D18 Dublin
See on map
Participation ended
80333 Muenchen
See on map
75654 Paris
See on map
T5J 4P6 EDMONTON ALBERTA
See on map
2 Dublin
See on map
2650 Edegem
See on map
708 52 Ostrava Poruba
See on map
76275 Zlin
See on map
75008 Paris
See on map